Get started
Work

LB951 Establishing a roadmap for therapeutics development for cutaneous neurofibromas

Year: 2017
Type: conference-abstract
DOI: 10.1016/j.jid.2017.07.025
Authors: S. Verma, P. Wolkenstein, L.Q. Le, J. Lee, B. Widemann, I. Brownell, K. Jarnagin, R.M. Lavker, E. Legius, R. Anderson, S. Plotkin, H. Weinberg, D. Casey, H. Ko, S. LaRosa, P. Knight, M. Parides, N. Bora, J. Morris, V. Riccardi, B. Korf, J. Blakeley
Institutions: Johns Hopkins University, Université Paris-Est Créteil, The University of Texas Southwestern Medical Center, Roivant Sciences (United States), National Cancer Institute, National Institutes of Health, Pfizer (United States), Northwestern University, KU Leuven, Massachusetts General Hospital, Harvard University, United States Food and Drug Administration, United States Department of Defense, University of Alabama at Birmingham
Language: English
Subfield: Neurology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2754619024
Cites:
Cited by:
Related to: 10